Belvedere Trading »

4d Molecular Therapeutics In shares owned by Belvedere Trading

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $711k 22k 31.86

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Put Option (META)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Spdr Gold Tr Gold Shs Put Option (GLD)
Microstrategy Cl A New Put Option (MSTR)
Ishares Silver Tr Ishares (SLV)
Coinbase Global Com Cl A (COIN)
Super Micro Computer (SMCI)
Graniteshares Etf Tr 2x Long Nvda Dai Call Option (NVDL)
Etf Opportunities Trust T Rex 2x Long (NVDX)

View all positions for Belvedere Trading

Top funds holding 4d Molecular Therapeutics In

RA Capital Management
VR Adviser
BlackRock
BVF
Henderson Group
Goldman Sachs Group
Viking Global Investors
Vanguard Group
Morgan Stanley
Redmile Group
Arrowpoint Asset Management
Braidwell
FMR
Geode Capital Management
Casdin Capital

View all funds holding 4d Molecular Therapeutics In